8:06 am Peregrine Pharma: Data Presented at AACR support potential of combining Peregrine’s PS-targeting immunotherapy agent Bavituximab with irradiation in Lung Cancer
View todays social media effects on PPHM
View the latest stocks trending across Twitter. Click to view dashboard
See who Peregrine is hiring next, click here to view
